Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's version. The change likely reflects backend or CMS maintenance rather than new study data.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is shown in the page footer, replacing the previous v3.6.0. This reflects a minor update to the page version metadata.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:32.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows recruitment is closed with the message 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The revision label was updated to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T12:34:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor software/UI update. It does not indicate changes to study content or data.
    Difference
    0.1%
    Check dated 2026-06-05T09:16:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.5.3 to v3.5.4, signaling a new version of the page. This metadata update does not modify the study details displayed.
    Difference
    0.1%
    Check dated 2026-05-15T04:19:33.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.5.2 to v3.5.3, reflecting a new release of the page's notes.
    Difference
    0.1%
    Check dated 2026-04-30T18:11:09.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.